INTRODUCTION
were estimated from published graphs by extracting images and determining the number of pixels in each 23 column and error bar relative to the scale bars on the axes. In all cases, enough data was included in the 24 manuscript body to confirm that at least one of the estimated values was correctly determined using this 25 method (such as total number of participants, or mean values in the highest or lowest genetic risk groups).
26
For each genotype and gene, 1,000 synthetic individuals were randomly generated to re-create a normally-27 distributed dataset with the same mean and SD characteristics as those in the associated publication. Each synthetic dataset was graphically represented using a violin plot to show the full distribution of the data.
5
Percent chance of a null effect from a risk allele was calculated by determining the percent overlap of the 6 normal distribution of the wild type phenotype with that of a risk genotype using statistics.NormalDist in 7 Python 3.8 Beta. The percent likelihood of the phenotype in a risk allele group being at or below the mean 8 value of the "wild type" was also calculated, and linear regression analysis was performed to determine the 9 percent contribution of risk alleles to a given phenotype. Similar analyses were performed using published 10 multi-SNP genetic risk scores for type 2 diabetes and obesity.3,4 11 12 Alternative methods
13
To encourage attempts to perform similar analyses, a number of free online tools can be used that do not 14 require significant technical skills. After calculating mean and SD as described above, free gaussian random 15 number generators such as from Random.org (https://www.random.org/gaussian-distributions/) can be used 16 to generate synthetic datasets. Though the Box-Muller transform used by this tool is unlikely to produce a 17 truly normal distribution,6 this is also unlikely to meaningfully affect the outcome. Similar online tools can be 18 used to determine the likelihood of being at, above, or below, a given point in a normal distribution to 19 determine null effects of a given SNP or risk score (http://onlinestatbook.com/2/calculators/normal_dist.html).
20
Finally, free online graphing software can be used to visually represent the datasets for visual examination heterogeneity in blood glucose levels was seen across the range of scores ( Figure 4A) . The likelihood of 9 null effect in the most common genetic score (score of 18, 14.3% of participants) was 84.5% ( Table 2 ). In 10 those with the highest genetic risk score (scores 21, 22, and >22), the risk of prediabetic level blood glucose 11 (>100mg/dl) was double that of those in the lowest risk group. However, even in these groups the likelihood 12 of a given genetic score being associated with blood sugar outside of the distribution of those in the lowest 13 risk group was only 25.5-27.7%, suggesting that fewer than 30% of people with the highest genetic risk of 14 prediabetes experience that risk as a disease phenotype. Across the entire range of scores, linear regression 15 found a significant association between risk score and fasting glucose (p<0.001, R2=0.049), suggesting that 16 around 5% of fasting glucose is determined by the 16 SNPs most significantly associated with type 2 diabetes 17 risk ( Figure 4B) 
23
This translates to a 0.09% and 0.05% risk of prediabetic fasting blood glucose, respectively. Therefore, even 24 in the lowest risk genetic group in the Framingham cohort, the relative risk of prediabetic fasting blood sugar 25 levels (19.4%) is around 200-400 times higher than in hunter gatherer populations. with reduced capacity to produce 5-methyltetrahydrofolate, are frequently discussed in the popular and more predictive, with more than a doubling of risk of prediabetes in those with the highest genetic frisk score 23 compared to those with the lowest genetic risk. However, linear regression analysis suggested that only 24 around 5% of fasting blood glucose is determined by genetic risk. This is just very similar to the proportion of 
27
More importantly, however, it the way in which this information is placed into the context of the consumer 28 using DTC genetic analysis to assess disease risk. For instance, the variance in fasting blood glucose (~5%)
29
attributed to the loci included in the genetic risk score is smaller than the variance in reproducibility of a recent analysis of the Bolivian Tsimane, prevalence of type 2 diabetes was 0%,17 on top of which any 5 increase in genetic risk would be essentially meaningless. Therefore, the presence of any prediabetes 6 appears to simply be a reflection of disease risk in the US as a whole, where more than 80% are thought to 7 have suboptimal metabolic health, including more than 50% with fasting glucose >100 mg/dl.18 Based on 8 multiple lines of evidence, close to 100% of the disease risk associated with elevated fasting blood glucose 9 in the Western world can be attributed to the modern environment.
10
The concept of methylation capacity and its association with long-term health has recently gained a 11 lot of interest in the alternative health community and popular press. As a result, DTC testing of common 
16
There was a significant association between MTHFR function and homocysteine (p<0.001, R2=0.01),
17
suggesting that only around 1% of the variability in homocysteine is determined by MTHFR activity across 18 these genotypes. 
